Palantir stock declines amid market jitters
Analysis based on 6 articles · First reported Jun 03, 2026 · Last updated Jun 09, 2026
The market is experiencing strong selling pressures across the S&P 500 and Nasdaq Composite due to concerns about AI stock valuations, macroeconomic risks, and potential interest rate hikes by the United States — Federal Reserve. Palantir stock is particularly affected by the potential loss of its United Kingdom — National Health Service contract and bearish sentiment from Michael Burry, leading to significant declines in its share price.
Palantir stock is facing significant sell-offs, down 26% year to date, driven by multiple factors. A primary concern is the potential loss of a $441 million contract with the United Kingdom's United Kingdom — National Health Service, which is under review by the United Kingdom government and scrutinized by British parliament members. Additionally, broader market pressures are impacting Palantir, including increased caution regarding valuations for AI stocks, macroeconomic risks, and investor jitters ahead of the United States — Bureau of Labor Statistics' CPI data release. The market is also weighing the implications of SpaceX's upcoming IPO and the possibility of the United States — Federal Reserve raising interest rates. Michael Burry has also reiterated his bearish stance on Palantir, further contributing to negative sentiment.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard